Logo image of RBOT

VICARIOUS SURGICAL INC-A (RBOT) Stock Fundamental Analysis

NYSE:RBOT - New York Stock Exchange, Inc. - US92561V2088 - Common Stock - Currency: USD

8.27  +0.32 (+4.03%)

Fundamental Rating

2

Overall RBOT gets a fundamental rating of 2 out of 10. We evaluated RBOT against 189 industry peers in the Health Care Equipment & Supplies industry. While RBOT has a great health rating, there are worries on its profitability. RBOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RBOT has reported negative net income.
In the past year RBOT has reported a negative cash flow from operations.
RBOT had negative earnings in 4 of the past 5 years.
In the past 5 years RBOT always reported negative operating cash flow.
RBOT Yearly Net Income VS EBIT VS OCF VS FCFRBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of RBOT (-93.36%) is worse than 79.89% of its industry peers.
Looking at the Return On Equity, with a value of -135.39%, RBOT is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -93.36%
ROE -135.39%
ROIC N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
RBOT Yearly ROA, ROE, ROICRBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

RBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBOT Yearly Profit, Operating, Gross MarginsRBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

7

2. Health

2.1 Basic Checks

RBOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RBOT has been reduced compared to 5 years ago.
There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RBOT Yearly Shares OutstandingRBOT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RBOT Yearly Total Debt VS Total AssetsRBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -5.17, we must say that RBOT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -5.17, RBOT is not doing good in the industry: 69.31% of the companies in the same industry are doing better.
There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.17
ROIC/WACCN/A
WACCN/A
RBOT Yearly LT Debt VS Equity VS FCFRBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 6.74 indicates that RBOT has no problem at all paying its short term obligations.
RBOT has a better Current ratio (6.74) than 85.19% of its industry peers.
A Quick Ratio of 6.74 indicates that RBOT has no problem at all paying its short term obligations.
The Quick ratio of RBOT (6.74) is better than 87.30% of its industry peers.
Industry RankSector Rank
Current Ratio 6.74
Quick Ratio 6.74
RBOT Yearly Current Assets VS Current LiabilitesRBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.19% over the past year.
EPS 1Y (TTM)26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

RBOT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.31% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y18.15%
EPS Next 2Y16.72%
EPS Next 3Y14.31%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBOT Yearly Revenue VS EstimatesRBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 20M 40M 60M 80M 100M
RBOT Yearly EPS VS EstimatesRBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBOT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBOT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBOT Price Earnings VS Forward Price EarningsRBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBOT Per share dataRBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

RBOT's earnings are expected to grow with 14.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.72%
EPS Next 3Y14.31%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RBOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VICARIOUS SURGICAL INC-A

NYSE:RBOT (5/2/2025, 8:19:33 PM)

8.27

+0.32 (+4.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-17 2025-03-17/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners34.47%
Inst Owner Change0%
Ins Owners2.01%
Ins Owner Change-0.01%
Market Cap49.04M
Analysts77.78
Price Target10.97 (32.65%)
Short Float %3.33%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.36%
Min EPS beat(2)-11.28%
Max EPS beat(2)13.99%
EPS beat(4)2
Avg EPS beat(4)2%
Min EPS beat(4)-11.28%
Max EPS beat(4)13.99%
EPS beat(8)5
Avg EPS beat(8)7.14%
EPS beat(12)7
Avg EPS beat(12)13.4%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.51%
PT rev (3m)-8.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)20%
EPS NY rev (1m)0%
EPS NY rev (3m)8.61%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.05
EV/EBITDA N/A
EPS(TTM)-10.85
EYN/A
EPS(NY)-8.88
Fwd EYN/A
FCF(TTM)-8.45
FCFYN/A
OCF(TTM)-8.42
OCFYN/A
SpS0
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -93.36%
ROE -135.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.54%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.74
Quick Ratio 6.74
Altman-Z -5.17
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)211.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.11%
EPS Next Y18.15%
EPS Next 2Y16.72%
EPS Next 3Y14.31%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.7%
EBIT Next 3Y21.22%
EBIT Next 5YN/A
FCF growth 1Y21.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.82%
OCF growth 3YN/A
OCF growth 5YN/A